鸡肾型传染性支气管炎病毒的分离鉴定

从陕西省榆林市某蛋用种鸡场疑似肾型传染性支气管炎病鸡中分离到了1株肾型IBV(定名为YL—04)，并对分离病毒进行了血凝性、血凝抑制性、致病性、鸡胚矮小化、电镜特征等生物学特性鉴定及S1基因5’端的RT—PCR鉴定。结果表明，该分离株经10g／L胰酶处理后的各代病毒尿囊收集液均可凝集鸡红细胞；标准阳性血清可特异性地抑制其凝集性；可复制出与自然发病相同的病例；病毒传代物有明显的致鸡胚矮小化作用；透射电镜下可见有近似球形、直径100nm左右的冠状病毒粒子；用RT—PCR方法扩增到1条373bp的目的片段，其核苷酸序列与IBVCQ／01／2004株序列的同源性达98％。     

鸡肾型传染性支气管炎病毒的分离及其N基因片段的克隆和测序

通过形态学观察、动物回归试验、鸡胚接种试验、病毒干扰试验以及血凝试验分离鉴定了1株肾型鸡传染性支气管炎病毒(IBV)。在透射电子显微镜下，病毒粒子多呈球形，直径为80～120nm，有囊膜，表面有冠状突起。鸡胚连续盲传至第1～2代，开始出现死亡或出现侏儒胚；分离株可显著干扰NDV在鸡胚中的增殖；病毒尿囊液无凝血活性，但经5g／L胰蛋白酶处理后。能够凝集10mL/L的鸡红细胞。利用RT—PCR技术对分离株的N基因进行了扩增，经克隆、序列测定和分析比较，证实分离株为肾型IBV，命名为AH3—04株。     

鸡传染性支气管炎病毒中国地方分离株M基因的分子特征

本实验根据已经发表的鸡传染性支气管炎病毒（IBV）M基因序列设计并合成一对引物，利用RT－PCR扩增得到了IBM新疆分离株LX4株（HA价为2^7)M基因678bp的片段，将该片段克隆到PUC18载体上，通过对所得到的重组质粒进行酶切分析，PCR鉴定，证明得到了含有目的基因片段的阳性重组质粒。采用Sanger's双脱氧末端终止法对插入片段进行核苷酸序列测定，获得了IBV－LX4株M基因的核苷酸序列，利用DNASIS分析软件，将它与GENBANK中发表的15株国外参考毒株相比较，发现核苷酸的同源性（除D1466和DE072外）为85％－92％，氨基酸的同源性为83％－92％，与国内参考株（H52－GD）相比分别为90％和92％，确证我们得到的克隆片段为IBV－LX4株的M基因，且含有两个糖基化位点，9个高度保守的半胱氨酸，三个跨膜区域，与国外的报道一致。     

鸡肾型传染性支气管炎病毒陕西地方株的分离与鉴定

对陕北(榆林)、关中(宝鸡市、扶风县)、陕南(洋县)等地鸡场疑似肾型传染性支气管炎病鸡，进行了病毒分离和鉴定。结果分离到4株IBV(定名为YL-04、BJ-04、FF-04、YX-04)，并对分离病毒进行了血凝性、血凝抑制性、致病性、鸡胚矮小化等生物学特性鉴定。结果发现，分离的4株病毒经1％胰酶处理后的各代病毒尿囊收集液均可凝集鸡红细胞；IBV标准阳性血清可特异性的抑制其凝集性；回归试验可复制出与自然发病相同的病例；病毒传代物有明显的致鸡胚矮小化作用。以上研究结果表明，我们分离到的是鸡传染性支气管炎病毒，临床表现为致肾脏病变的组织嗜性，证明以上地区鸡群发病与肾型传染性支气管炎病毒感染有关。     

鸡传染性支气管炎病毒HN株5a5b及N基因的遗传变异分析

从河南省某鸡场中疑似鸡传染性支气管炎(IB)的雏鸡病料中分离到1株鸡传染性支气管炎病毒(IBV)，暂命名为HN，鉴定为IBV。从接种HN毒株的鸡胚尿囊液中提取单股RNA后应用反转录-聚合酶链反应(RT—PCR)技术扩增得到包含IBV HN株5a、5b蛋白及N蛋白基因的约1600bp片段；将克隆测序的5a、5b及N基因分别与GenBank中11株国内外参考毒株相应基因进行序列比较与遗传变异分析，发现IBV HN株变异独特，明显不同于国内外参考毒株。     

鸭新城疫病毒和流感病毒多重RT-PCR鉴别诊断技术的建立和应用

对同样以引起鸭产蛋下降为主要特征的鸭流感病毒（AIV）分离株和鸭新城疫病毒（NDV）YH99V分离株，通过设计特异性引物和优化体系反应条件，建立了一种早期快速鉴别诊断鸭AIV和鸭NDV的单项RT—PCR方法和多重RT—PCR方法，AIV的扩增片段大小为483bp，NDV的扩增片段为310bp，电泳快速，易于区分。敏感性试验表明，该方法比HA敏感100倍以上；对AIV、YH99V、IBV、IBDV及正常鸡胚尿囊液的混合液检测显示，多重RT—PCR法具有很强的特异性。对鸭病毒性产蛋下降征侯群送检病料的检测证明，该方法能有效鉴别AIv和／或NDV单独感染或混合感染，阳性检出率明显高于HA方法。     

二温式多重PCR同时检测鸡的6种呼吸道病病原方法的建立

设计了6对分别针对鸡传染性支气管炎病毒（IBV），禽流感病毒（AVI）、鸡毒素霉形体（MG）、鸡传染性喉气管炎病毒（ILTV）、新城疫病毒（NDV）和滑液霉形体（MS）的特异性引物，根据反转录滞酶链反应（RT－PCR）和多重PCR原则，优化建立了一次PCR反应同时检测6种禽呼吸道病原的二温式多重PCR。该方法可同时扩增出6条区段大小与设计相符符的特异性片段，即IBV 1720bp,AIV 1050bp,ILTV647bp,NDV310bp,MS207bp，对人工感染鸡临床样品检测结果证明，该方法可用于临床诊断。     

鸡传染性支气管炎病毒中国地方分离株S1基因5''端的变异

对自海南海省、广西省发生鸡传染性支气管炎（IB）鸡群分离的4株IBV分离株（HaN-1/95、HaN-2/95、GX-1/98、GX－2／98）的主要免疫原纤突蛋白S1基因经RT－PCR扩增其5'端的1．2kb的目的片段，将其插入载体pMD 18-Tk ,在大肠杆菌中实现目的的基因的克隆。对克隆的目的基因经限制性酶切分析及PCR鉴定后，以双脱氧链终止法测定其核苷酸序列，并与GenBank中的参考毒株（H120、SD－1／97和Holte）相应序列作比较，分析其同源性。结果表明，HaN-1/95、HaN-2/95、GX-1/98及SD－1／97与疫苗株H120的核苷酸序列同源性分别为99．5％、99．2％、97．9％和99．5％，其推导氨基酸序列同源性分别为99．1％、98．9％、96．9％和99．2％。GX－2／98与Holte株的核苷酸序列同源率为99．0％，其推导的氨基酸序列同源性为98．6％，而与其他中国分离株的核苷酸序列的同源性仅为70％左右，氨基酸序列的同源性仅为68％左右。     

鸡传染性支气管炎病毒793/B RT-PCR检测方法的建立及应用

根据GenBank已发表的鸡传染性支气管炎病毒（Infectious bronchitis virus，IBV）793／BS1基因序列，设计1对引物，扩增891bp特异性核酸片段，建立了检测IBV793／B的RT—PCR方法。特异性试验结果表明，IBV793／B能扩增出891bp的核酸片段，而IBVM41H120H52毒株以及新城疫病毒（NDV）、禽流感病毒（AIV）、传染性法氏囊病病毒（IBDV）均无特异性条带出现。敏感性试验结果表明，该方法的最低检出量为10pg的模板。上述结果表明，本试验所建立的RT—PCR方法敏感性高、特异性强。利用建立的RT—PCR方法对从山东省分离的8株疑似鸡IBV793／B进行检测，结果7株为阳性。该方法的建立为IBV793／B的诊断及流行病学调查提供了可靠的方法。     

鸡肾型IBV JL株的分离和鉴定

研究通过电镜形态学观察、理化特性测定、致鸡胚矮小化试验、血凝试验、NDV毒株干扰试验、中和试验和致病力试验,分离、鉴定出1株鸡肾型传染性支气管炎病毒当地毒株(IBV JL株),为下一步进行鸡肾型传染性支气管炎疫苗制备的研究提供了毒种.     

白术、微米白术和白术多糖对断奶仔猪生长性能和肠道形态及微生态区系的影响

试验选用96头平均体重14.82 kg左右的杜×长×大断奶仔猪,随机分成4组,每组3栏,每栏8头(公母各半)。对照组饲喂基础日粮,试验1、2、3组分别添加1%80目白术、0.2%白术多糖和1%微米白术。试验期30 d。结果表明:在生长性能方面,与对照组相比,1%微米白术添加组可显著提高日增重(P0.05)、降低饲料增重比和腹泻率,而且效果优于1%80目白术组和0.2%白术多糖组,在肠道形态和肠道微生态区系方面,与对照组相比,日粮添加1%80目白术、0.2%白术多糖、1%微米白术均可不同程度的提高十二指肠和空肠的绒毛高度,加深十二指肠和空肠的隐窝深度,并且增加肠道微生态区系的多样性,其中以1%微米白术添加组的效果最佳。     

Prevalence and seasonal incidence of nematode parasites and fluke infections of sheep and goats in eastern Ethiopia

Sissay, M.M., Uggla, A. and Waller, P.J., XXXX. Prevalence and seasonal incidence of nematode parasites and fluke infections of sheep and goats in eastern Ethiopia. Tropical Animal Health and Production, XXXX. A 2-year abattoir survey was carried out to determine the prevalence, abundance and seasonal incidence of gastro-intestinal (GI) nematodes and trematodes (flukes) of sheep and goats in the semi-arid zone of eastern Ethiopia. During May 2003 to April 2005, viscera including liver, lungs and GI tracts were collected from 655 sheep and 632 goats slaughtered at 4 abattoirs located in the towns of Haramaya, Harar, Dire Dawa and Jijiga in eastern Ethiopia. All animals were raised in the farming areas located within the community boundaries for each town. Collected materials were transported within 24 h to the parasitology laboratory of Haramaya University for immediate processing. Thirteen species belonging to 9 genera of GI nematodes (Haemonchus contortus, Trichostrongylus axei, T. colubriformis, T. vitrinus, Nematodirus filicollis, N. spathiger, Oesophagostomum columbianum, O. venulosum, Strongyloides papillosus, Bunostomum trigonocephalum, Trichuris ovis, Cooperia curticei and Chabertia ovina), and 4 species belonging to 3 genera of trematodes (Fasciola hepatica, F. gigantica, Paramphistomum {Calicohoron} microbothrium and Dicrocoelium dendriticum) were recorded in both sheep and goats. All animals in this investigation were infected with multiple species to varying degrees. The mean burdens of adult nematodes were generally moderate in both sheep and goats and showed patterns of seasonal abundance that corresponded with the bi-modal annual rainfall pattern, with highest burdens around the middle of the rainy season. In both sheep and goats there were significant differences in the mean worm burdens and abundance of the different nematode species between the four geographic locations, with worm burdens in the Haramaya and Harar areas greater than those observed in the Dire Dawa and Jijiga locations. Similar seasonal variations were also observed in the prevalence of flukes. But there were no significant differences in the prevalence of each fluke species between the four locations. Overall, the results showed that Haemonchus, Trichostrongylus, Nematodirus, Oesophagostomum, Fasciola and Paramphistomum species were the most abundant helminth parasites of sheep and goats in eastern Ethiopia.     

Phase I evaluation of CCNU (lomustine) in tumor-bearing cats

1-(2-Chloroethyl)3-cyclohexyl-1-nitrosourea (CCNU) is an alkylating agent in the nitrosourea subclass. A prospective evaluation of CCNU was done to determine the maximally tolerated dosage of CCNU in tumor-bearing cats. Response data were obtained when available. Twenty-five cats were treated with CCNU at a dosage of 50-60 mg/m3 body surface area. Complete hematologic data were available for 13 cats. Neutropenia was the acute dose-limiting toxicity. The median neutrophil count at the nadir was 1,000 cells/microL (mean, 2,433 cells/microL; range, 0-9,694 cells/microL). The time of neutrophil nadir was variable, occurring 7-28 days after treatment, and counts sometimes did not return to normal for up to 14 days after the nadir. Based on these findings, a 6-week dosing interval and weekly hematologic monitoring after the 1st treatment with CCNU are recommended. The nadir of the platelet count may occur 14-21 days after treatment. The median platelet count at the nadir was 43,500 cells/microL. No gastrointestinal, renal, or hepatic toxicities were observed after a single CCNU treatment, and additional studies to evaluate the potential for cumulative toxicity should be performed. Five cats with lymphoma and 1 cat with mast cell tumor had measurable responses to CCNU. Phase II studies to evaluate antitumor activity should be completed with a dosing regimen of 50-60 mg/m3 every 6 weeks.     

Y‐chromosomal variation of local goat breeds of Turkey close to the domestication centre

Genetic variations in chromosome Y are enabling researchers to identify paternal lineages, which are informative for introgressions and migrations. In this study, the male‐specific region markers, sex‐determining region‐Y (SRY), amelogenin (AMELY) and zinc finger (ZFY) were analysed in seven Turkish native goat breeds, Angora, Kilis, Hair, Honaml?, Norduz, Gürcü and Abaza. A SNP in the ZFY gene defined a new haplotype Y2C. All domestic haplogroups originate from Capra aegagrus, while the finding of Y1A, Y1B, Y2A and Y2C in 32, 4, 126 and 2 Turkish domestic goats, respectively, appears to indicate a predomestic origin of the major haplotypes. The occurrence of four haplotypes in the Hair goat and, in contrast, a frequency of 96% of Y1A in the Kilis breed illustrate that Y‐chromosomal variants have a more breed‐dependent distribution than mitochondrial or autosomal DNA. This probably reflects male founder effects, but a role in adaptation cannot be excluded.     

Prevalence of gastric lesions in racing Alaskan sled dogs

Human and equine athletes are reported to have a high prevalence of gastric disease, and anecdotal evidence suggests a similar phenomenon applies to racing sled dogs. To investigate the prevalence of gastric disease in racing sled dogs, we conducted 2 gastroscopy studies on dogs competing in the annual Iditarod Sled Dog Race. A pilot study of dogs that were either dropped from the 2000 Iditarod Sled Dog Race because of illness or that finished the race indicated that, approximately 5 days after competing, 10 of 28 dogs (35%) had endoscopic evidence of gastric ulceration, erosion, or hemorrhage. The next year, an endoscopic study of 73 dogs participating in the 2001 Iditarod race was performed in order to evaluate a larger population of dogs. Data from 70 of these dogs could be used; 34 (48.5%) had ulceration, erosion, gastric hemorrhage, or some combination of these findings. When this group of 70 dogs was compared retrospectively to a control group of 87 dogs presented to the Texas A&M University (TAMU) Veterinary Medical Teaching Hospital, the Iditarod sled dogs had a significantly higher prevalence (P = .049) of gastric lesions. These findings suggest that, similar to athletes of other species, elite canine athletes have an increased prevalence of gastric disease compared to the canine population at large.     

Furosemide continuous rate infusion in the horse: evaluation of enhanced efficacy and reduced side effects

Continuous rate infusion (CRI) of furosemide in humans is considered superior to intermittent administration (IA). This study examined whether furosemide CRI, compared with IA, would increase diuretic efficacy with decreased fluid and electrolyte fluctuations and activation of the renin-angiotensin-aldosterone system (RAAS) in the horse. Five mares were used in a crossover-design study. During a 24-hour period, each horse received a total of 3 mg/kg furosemide by either CRI (0.12 mg/kg/h preceded by a loading dose of 0.12 mg/kg IV) or IA (1 mg/kg IV q8h). There was not a statistically significant difference in urine volume over 24 hours between methods; however, urine volume was significantly greater after CRI compared with IA during the first 8 hours ([median 25th percentile, 75th percentile]: 9.6 L [8.9, 14.4] for CRI versus 5.9 L [5.3, 6.0] for IA). CRI produced a more uniform urine flow, decreased fluctuations in plasma volume, and suppressed renal concentrating ability throughout the infusion period. Potassium, Ca, and Cl excretion was greater during CRI than IA (1,133 mmol [1.110, 1,229] versus 764 mmol [709, 904], 102.7 mmol [96.0, 117.2] versus 73.3 mmol [65.0, 73.5], and 1,776 mmol [1,657, 2.378] versus 1,596 mmol [1,457, 1,767], respectively). Elimination half-lives of furosemide were 1.35 and 0.47 hours for CRI and IA, respectively. The area under the excretion rate curve was 1,285.7 and 184.2 mL x mg/mL for CRI and IA, respectively. Furosemide CRI (0.12 mg/kg/h) for 8 hours, preceded by a loading dose (0.12 mg/kg), is recommended when profound diuresis is needed acutely in horses.     

Feline intracranial neoplasia: retrospective review of 160 cases (1985-2001)

The purpose of this study was to determine the frequency of different tumor types within a large cohort of cats with intracranial neoplasia and to attempt to correlate signalment, tumor size and location, and survival time for each tumor. Medical records of 160 cats with confirmed intracranial neoplasia evaluated between 1985 and 2001 were reviewed. Parameters evaluated included age, sex, breed, FeLV/FIV status, clinical signs, duration of signs, number of tumors, tumor location(s), imaging results, treatment, survival times, and histopathologic diagnosis. Most of the cats were older (11.3 +/- 3.8 years). Primary tumors accounted for 70.6% of cases. Metastasis and direct extension of secondary tumors accounted for only 5.6 and 3.8% of cases, respectively. Twelve cats (7.5%) had 2 or more discrete tumors of the same type, whereas 16 cats (10.0%) had 2 different types of intracranial tumors. The most common tumor types were meningioma (n = 93, 58.1%), lymphoma (n = 23, 14.4%), pituitary tumors (n = 14, 8.8%), and gliomas (n = 12, 7.5%). The most common neurological signs were altered consciousness (n = 42, 26.2%), circling (n = 36, 22.5%), and seizures (n = 36, 22.5%). Cats without specific neurological signs were common (n = 34, 21.2%). The tumor was considered an incidental finding in 30 (18.8%) cats. In addition to expected relationships (eg, meninges and meningioma, pituitary and pituitary tumors), we found that lesion location was predictive of tumor type with diffuse cerebral or brainstem involvement predictive of lymphoma and third ventricle involvement predictive of meningioma.     

The Epidemiology of Gastrointestinal Nematodes of Dairy Cattle in Central Kenya

The epidemiology of H. placei and of other gastrointestinal nematodes in yearling dairy cattle was examined on two farms in Kiambu District, central Kenya during each of 13 one-month periods from April 1993 to April 1994. On each farm, 32 newly weaned dairy calves were given a single dose of albendazole and then placed on experimental pastures. Twelve of the animals were designated for bi-monthly slaughter (n = 2) and analysis of worm population characteristics and 20 were designated for blood and faecal collection and for weighing. Two parasite-free tracer calves were grazed alongside the weaner calves each month throughout the study period and were also slaughtered for analysis of worm populations. Faecal egg counts, haematological and serum pepsinogen determinations, herbage larval counts, and animal live weight changes were recorded monthly. The study revealed that Haemonchus placei, Trichostrongylus axei, Cooperia spp. and Oesophagostomum radiatum were responsible for parasitic gastroenteritis and that H. placei was the predominant nematode present in the young cattle on both farms. Faecal egg counts from resident cattle and necropsy worm counts revealed that pasture larval levels were directly related to the amount of rainfall. The total worm burdens in the animals were highest during the rainy season (March–June and October–December) and lowest during the dry seasons (July–September and January–February). The very low recovery of immature larvae of H. placei from the tracer calves indicated that arrested development is not a feature of the life cycle of this parasite in central Kenya. The maintenance of the parasite population depended on continuous cycling of infection between the host and the pasture. The agroclimatic conditions of the study area were such that, in general, favourable weather conditions for the development and survival of the free-living stages of gastrointestinal nematodes existed all year round.     

Diversity of Ectoparasites in Sheep Flocks in Sa~o Paulo,Brazil

The occurrence of ectoparasites in sheep flocks is frequently reported but seldom quantified. Sheep production used to be a predominantly family activity in the state of Sa~o Paulo (Brazil), but it began to become a commercial activity in the past decade. Thus, information about the ectoparasites existing in sheep flocks has become necessary. The present data were obtained by means of questionnaires sent to all sheep breeders belonging to the `Associaça~o Paulista de Criadores de Ovinos' (ASPACO; Sa~o Paulo State Association of Sheep Breeders). Response reliability was tested by means of random visits paid to 10.6% of the respondents. Most of the properties (89.5%) reported the presence of one or more ectoparasites. Screw-worm (Cochliomyia hominivorax) was the most frequent ectoparasite (72.5%), followed by bot fly larvae (Dermatobia hominis, 45.0%), ticks (Amblyomma cajennense) and Boophilus microplus, 31.3%) and finally lice (Damalinia ovis, 13.8%). Combined infestations also occurred, the most common one being screw-worm with bot fly larvae (36.0%) followed by bot fly larvae with ticks (13.9%), screw-worm with ticks (9.3%), bot fly larvae with lice (6.9%), and ticks with lice (5.0%). The most common triple combination was screw-worm, bot fly larvae and ticks (12.8%). Breeds raised for meat or wool were attacked by bot fly larvae and ticks more often than other breeds. Lice were only absent from animals of indigenous breeds. The relationships among these ectoparasites are discussed in terms of sheep breeds, flock size, seasonality and the ectoparasitic combinations on the host.     

A brief history of the prevention of infectious diseases by immunisations

Infectious diseases have always been a terrible scourge for humans. The appearance of these plagues, as they were called without distinction, was generally connected to various conditions: asters, climatic changes or religious reasons. The concept of contagious, and then infectious, diseases came slowly. Variolation, i.e. transmission of ‘virulent’ matter to induce a natural disease and the immunity against it, was brought from Constantinople to England by Lady Montague, in 1721. This ‘variolation’ technique was also often performed in veterinary medicine against diseases like sheep-pox or pleuropneumonia. As ‘vaccination’ is the term generally accepted for ‘immunisation’, variolation can be the word designating such a technique. The second period of the history of immunisation began, in 1880, with the studies of Pasteur and his collaborators. A great number of bacterial vaccines were developed: dead, live but attenuated or only parts of pathogens. The viruses were produced in animals, then in eggs and at last, in tissue cultures. Second generation vaccines appeared with genetic engineering: recombinant vaccines, vector vaccines, nucleic acids vaccines, and markers vaccines, among others. These novel technologies can permit the development of new ones and improve the quality of the vaccines already existing.